SynGenSys

SynGenSys is a synthetic biology company developing proprietary libraries of synthetic gene promoters and signal peptides designed to improve the yield, specificity, and reliability of recombinant protein expression.

Its computational platform uses bioinformatics and AI to design novel promoters from first principles, tailored to specific cell types including CHO cells for biologics manufacturing and T-cells for gene therapy.

The technology is offered as both off-the-shelf and bespoke libraries to pharmaceutical and biotechnology customers.